Shares of eyecare company Bausch + Lomb (NYSE...Following the trial results, Bausch + Lomb stated it will stop developing the eye drops for glaucoma ... Is now the time to buy Bausch + Lomb? Access our full ...
This is the Conflict Minerals Report ("Report") of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") for calendar year 2025, prepared and submitted in ...
At the Annual Meeting of Shareholders (the "Annual Meeting") of Bausch + Lomb Corporation (the "Company") held on Wednesday, May 20, 2026, the Company's ... Bausch + Lomb Corp.